LDK378, a USA-FDA approved ALK inhibitor, was shown to exhibit anti-inflammatory effect and potent to confer protection against lethal endotoxemia and sepsis in mice.359 Other approach that interfere with interaction between toxins/alarmins and their reciprocal receptor also result in attenuated cytokine gene expression and inflammatory responses. The gene discussed is ALK; the disease is Sepsis.